A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102
Clinical trial NCT04109092 · WITHDRAWN
Trial details
- NCT number
- NCT04109092
- Sponsor
- Eisai Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-13
- Primary completion
- 2022-09-29
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.